# 7 days of L-citrulline supplementation does not improve running performance in the heat whilst in a hypohydrated state

**Authors:** Thomas G. Cable, Mark P. Funnell, Kirsty M. Reynolds, Ella F. Hudson, Heather Z. Macrae, Drusus A. Johnson, Lee Taylor, Liam M. Heaney, Stephen A. Mears, Stephen J. Bailey, Lewis J. James

PMC · DOI: 10.1007/s00421-024-05671-4 · European Journal of Applied Physiology · 2024-12-19

## TL;DR

Seven days of L-citrulline supplementation does not improve running performance in hot conditions when runners are mildly dehydrated.

## Contribution

This study is the first to investigate the effects of L-citrulline on running performance in heat under hypohydration.

## Key findings

- L-citrulline had no effect on 3 km running performance in hot conditions.
- Thermoregulation and gastrointestinal damage were unaffected by L-citrulline.
- No differences in physiological or perceptual responses were observed between L-citrulline and placebo.

## Abstract

7 days L-citrulline supplementation has been reported to improve blood pressure, \documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathop {\text{V}}\limits^{.}$$\end{document}V.O2 kinetics, gastrointestinal (GI) perfusion and endurance cycling performance through increasing arterial blood flow. In situations where blood volume is compromised (e.g., hyperthermia/hypohydration), L-citrulline may improve thermoregulation and exercise performance by redistributing blood flow to aid heat loss and/or muscle function. This study assessed 7 days L-citrulline supplementation on running performance in the heat, whilst mildly hypohydrated.

13 endurance runners (2 female, 31 ± 8 y, \documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathop {\text{V}}\limits^{.}$$\end{document}V.O2peak 60 ± 6 mL/kg/min) participated in a randomised crossover study with 7 days L-citrulline (CIT; 6 g/d) or placebo (maltodextrin powder; PLA) supplementation. Participants completed a 50 min running ‘preload’ at 65% \documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathop {\text{V}}\limits^{.}$$\end{document}V.O2peak (32 °C, 50% relative humidity) to induce hyperthermia and hypohydration before a 3 km running time trial (TT). Body mass and blood samples were collected at baseline, pre-preload, post-preload and post-TT, whilst core and skin temperature, heart rate and perceptual responses were collected periodically throughout.

TT performance was not different between trials (CIT 865 ± 142 s; PLA 892 ± 154 s; P = 0.437). Core and skin temperature and heart rate (P ≥ 0.270), hydration (sweat rate, plasma volume, osmolality) indices (P ≥ 0.216), GI damage (P ≥ 0.260) and perceptual responses (P ≥ 0.610) were not different between trials during the preload and TT.

7 days of L-citrulline supplementation had no effect on 3 km running performance in the heat or any effects on thermoregulation or GI damage in trained runners in a hypohydrated state.

The online version contains supplementary material available at 10.1007/s00421-024-05671-4.

## Linked entities

- **Chemicals:** L-citrulline (PubChem CID 833)

## Full-text entities

- **Diseases:** hyperthermia (MESH:D005334), GI damage (MESH:D005767)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12055621/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12055621/full.md

---
Source: https://tomesphere.com/paper/PMC12055621